To access this element change to forms mode OFF
Grant Award View - GA276614
Leveraging liver-derived extracellular vesicles to identify new...
GA ID:
GA276614
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
1-Sep-2022
Publish Date:
19-Dec-2022
Category:
Medical Research
Grant Term:
1-Jan-2023 to 31-Dec-2027
Value (AUD):
$655,150.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Leveraging liver-derived extracellular vesicles to identify new therapies for type 2 diabetes
Purpose:
Type 2 diabetes is characterised by impairments in glycemic control, compromised insulin secretion, and insulin resistance. There is an urgent clinical need to develop new strategies to normalise blood glucose levels. This investigator grant aims to identify novel insulin-independent therapeutic targets that can improve glycemic control. This project will use preclinical models to validate the efficacy of these targets, setting the stage for the development of new treatments for type 2 diabetes.
GO ID:
GO Title:
Investigator Grants 2022
Internal Reference ID:
2022/GNT2018187
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA